Waypoint Bio

OverT Bio

This company develops engineered cell therapies and genetic screening platforms to treat patients with solid tumour cancers.

CTRL Therapeutics

This company develops cell therapies for solid tumours and microfluidic platforms to identify rare tumour-reactive lymphocytes for cancer patients.

Captain T Cell

The company develops cell therapies for cancer patients to treat solid tumours.

Outpace Bio

This biotechnology company develops custom protein-designed cell therapies to treat solid tumours and autoimmune diseases for patients and pharmaceutical partners.

OverT

This biotechnology company develops engineered cell therapies for the treatment of solid tumours in cancer patients.

Kindling Bio

This company develops a gene therapy platform that engineers tumour cells to display markers for the immune system to treat children with solid tumours.

Swarm Oncology

This biotechnology company develops personalised T cell therapies for patients with advanced solid cancers to achieve long-term remission.

Cytospire Therapeutics

This company develops multispecific immune cell engager antibodies for cancer patients to enhance and direct immune system activity against solid tumours.